Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9217 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.9018 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8935 |
High Similarity |
NPD7074 |
Phase 3 |
0.8837 |
High Similarity |
NPD8313 |
Approved |
0.8837 |
High Similarity |
NPD8312 |
Approved |
0.878 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8765 |
High Similarity |
NPD7054 |
Approved |
0.8713 |
High Similarity |
NPD7472 |
Approved |
0.8671 |
High Similarity |
NPD7808 |
Phase 3 |
0.865 |
High Similarity |
NPD4380 |
Phase 2 |
0.8613 |
High Similarity |
NPD7251 |
Discontinued |
0.8606 |
High Similarity |
NPD8455 |
Phase 2 |
0.8555 |
High Similarity |
NPD6797 |
Phase 2 |
0.8521 |
High Similarity |
NPD6959 |
Discontinued |
0.8488 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.848 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.848 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.848 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.848 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8452 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.84 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8389 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8352 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8343 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8284 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8274 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8274 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8263 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8176 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8166 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8137 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8137 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8115 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.8107 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8107 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8086 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8035 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8031 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.8031 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.8011 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7978 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7947 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7947 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7947 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7919 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7906 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7906 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7884 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7884 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7884 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7884 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7884 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7884 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7884 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7876 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7865 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7853 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7849 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7841 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7841 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7824 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7821 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7812 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7812 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7811 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7803 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7791 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7765 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7755 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7744 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7738 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7738 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7732 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7708 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7704 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7704 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7701 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7674 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7657 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7647 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7632 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7619 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7605 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.756 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7546 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7543 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7531 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7527 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.75 |
Intermediate Similarity |
NPD2800 |
Approved |
0.75 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7487 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7486 |
Intermediate Similarity |
NPD37 |
Approved |
0.7472 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7458 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7458 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7458 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7456 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7456 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7415 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7403 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7399 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7384 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7384 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7384 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7384 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7382 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7382 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7382 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7366 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7351 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7349 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7344 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7344 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7337 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7337 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7337 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7321 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7317 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7314 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7314 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7302 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7299 |
Intermediate Similarity |
NPD920 |
Approved |
0.7286 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7283 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7262 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7257 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7232 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7219 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7212 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7176 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7168 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7158 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7156 |
Intermediate Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.7156 |
Intermediate Similarity |
NPD8059 |
Phase 3 |
0.7126 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7126 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7122 |
Intermediate Similarity |
NPD7930 |
Approved |
0.712 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7118 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7118 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7107 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7093 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7093 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7081 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7081 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7076 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7076 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7073 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7071 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7065 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7052 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7052 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7047 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7024 |
Intermediate Similarity |
NPD943 |
Approved |
0.7018 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7018 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7018 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7018 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7011 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7011 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7006 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.6995 |
Remote Similarity |
NPD919 |
Approved |
0.6988 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6982 |
Remote Similarity |
NPD1933 |
Approved |
0.6982 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6975 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6973 |
Remote Similarity |
NPD5711 |
Approved |
0.6973 |
Remote Similarity |
NPD5710 |
Approved |
0.6959 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6954 |
Remote Similarity |
NPD4361 |
Phase 2 |
0.6954 |
Remote Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.6936 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6919 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6915 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD6190 |
Approved |
0.6909 |
Remote Similarity |
NPD1203 |
Approved |
0.6905 |
Remote Similarity |
NPD3268 |
Approved |
0.6898 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6868
|
Remote Similarity |
NPD5760 |
Phase 2 |